Rheumnow Podcast

Dr. Jack Cush reviews the FDA approvals, news and the latest journal articles from the past week on RheumNow.com

Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.com; plus questions & cases from viewers in (#ACA) Ask Cush Anything.

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections...

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or...

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia...

Dr Jack Cush reviews the news and journal reports and takes cases and questions from rheumatologists

Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)

Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com

Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)

Dr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19

Dr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Dr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com

Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease. Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG

Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease. Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG

Dr Jack Cush reviews rheumatology and COVID news from the past week on RheumNow.com

Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com